Recombinant Human BACE1 protein, His & GST-tagged
Cat.No. : | BACE1-713H |
Product Overview : | Recombinant Human BACE1 aa. (Phe170~Thr428 (Accession# P56817)) fused with N-terminal His & GST tag was produced in E. coli cells. |
- Specification
- Gene Information
- Related Products
Description : | This gene encodes a member of the peptidase A1 family of aspartic proteases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protease. This transmembrane protease catalyzes the first step in the formation of amyloid beta peptide from amyloid precursor protein. Amyloid beta peptides are the main constituent of amyloid beta plaques, which accumulate in the brains of human Alzheimer's disease patients. |
Source : | E. coli |
Species : | Human |
Tag : | His & GST |
Form : | Freeze-dried powder |
Molecular Mass : | Predicted Molecular Mass: 59.1kDa |
Protein length : | Phe170~Thr428 (Accession# P56817) |
Endotoxin : | <1.0EU per 1µg (determined by the LAL method) |
Purity : | >90% |
Characteristic : | The isoelectric point is 5.2. |
Applications : | SDS-PAGE; WB; ELISA; IP |
Stability : | The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition. |
Storage : | Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months. |
Storage buffer : | Supplied as lyophilized form in 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, and preservative |
Reconstitution : | Reconstitute in sterile ddH2O. |
Gene Name : | BACE1 beta-secretase 1 [ Homo sapiens (human) ] |
Official Symbol : | BACE1 |
Synonyms : | BACE1; beta-secretase 1; ASP2; BACE; HSPC104; beta-secretase 1; APP beta-secretase; asp 2; aspartyl protease 2; beta-secretase 1 precursor variant 1; beta-site APP cleaving enzyme 1; beta-site APP-cleaving enzyme; beta-site amyloid beta A4 precursor protein-cleaving enzyme; memapsin-2; membrane-associated aspartic protease 2; transmembrane aspartic proteinase Asp2 |
Gene ID : | 23621 |
mRNA Refseq : | NM_001207049.1 |
Protein Refseq : | NP_001193978.1 |
UniProt ID : | P56817 |
Products Types
◆ Recombinant Protein | ||
BACE1-331R | Recombinant Rhesus Macaque BACE1 Protein, His (Fc)-Avi-tagged | +Inquiry |
Bace1-1815M | Recombinant Mouse Bace1 Protein, Myc/DDK-tagged | +Inquiry |
BACE1-587R | Recombinant Rat BACE1 Protein, His (Fc)-Avi-tagged | +Inquiry |
Bace1-252M | Active Recombinant Mouse Bace1 protein(Met1-Thr457), His-tagged | +Inquiry |
BACE1-2200H | Recombinant Human BACE1 Protein, MYC/DDK-tagged | +Inquiry |
◆ Lysates | ||
BACE1-3006HCL | Recombinant Human BACE1 cell lysate | +Inquiry |
BACE1-3077MCL | Recombinant Mouse BACE1 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionYes, several clinical trials are underway to assess the safety and efficacy of BACE1 inhibitors in treating Alzheimer's disease.
BACE1 is implicated in Alzheimer's disease as it initiates the cleavage of APP, leading to the formation of beta-amyloid plaques, a hallmark of the disease.
BACE1 inhibitors may slow down or prevent the accumulation of beta-amyloid plaques, potentially delaying the progression of Alzheimer's disease.
Yes, several clinical trials are underway to assess the safety and efficacy of BACE1 inhibitors in treating Alzheimer's disease.
Yes, BACE1 inhibitors are being explored as potential therapeutic agents for Alzheimer's disease to reduce the production of beta-amyloid peptides.
Customer Reviews (3)
Write a reviewSuch support ensures researchers have access to reliable tools and expertise, facilitating their investigations into the functions, mechanisms, and disease relevance of BACE1 protein.
A manufacturer can serve as a collaborative partner, engaging in discussions, and exchanging knowledge with researchers.
Using BACE1 protein in trials provides advantages such as its involvement in cellular processes and its disease associations.
Ask a Question for All BACE1 Products
Required fields are marked with *
My Review for All BACE1 Products
Required fields are marked with *
Inquiry Basket